Your browser doesn't support javascript.
loading
The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: A critical review.
Marta, Gustavo Nader; Coles, Charlotte; Kaidar-Person, Orit; Meattini, Icro; Hijal, Tarek; Zissiadis, Yvonne; Pignol, Jean-Philippe; Ramiah, Duvern; Ho, Alice Y; Cheng, Skye Hung-Chun; Sancho, Gemma; Offersen, Birgitte Vrou; Poortmans, Philip.
Afiliación
  • Marta GN; Department of Radiation Oncology - Hospital Sírio-Libanês, São Paulo, Brazil; Department of Radiology and Oncology - Division of Radiation Oncology, Instituto do Câncer do Estado de São Paulo (ICESP), Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. Electronic address: gustavo.
  • Coles C; Department of Oncology, University of Cambridge, Cambridge, UK. Electronic address: colesc@doctors.org.uk.
  • Kaidar-Person O; Breast Cancer Radiation Unit, Radiation Oncology Institute, Sheba Medical Center, Ramat Gan, Israel. Electronic address: Orit.KaidarPerson@Sheba.health.gov.il.
  • Meattini I; Radiation Oncology Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy; Department of Experimental and Clinical Biomedical Sciences "M. Serio", University of Florence, Florence, Italy. Electronic address: icro.meattini@unifi.it.
  • Hijal T; Division of Radiation Oncology, McGill University Health Centre, Montréal, Quebec, Canada. Electronic address: tarek.hijal@muhc.mcgill.ca.
  • Zissiadis Y; Department of Radiation Oncology, Genesis Cancer Care, Wembley, Western Australia, Australia. Electronic address: Yvonne.Zissiadis@genesiscancercare.com.au.
  • Pignol JP; Department of Radiation Oncology, Dalhousie University, Halifax, Canada. Electronic address: jean-philippe.pignol@dal.ca.
  • Ramiah D; Department of Radiation Oncology, Donald Gordon Medical Centre, Johannesburg, South Africa. Electronic address: dr@roncology.com.
  • Ho AY; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA. Electronic address: Alice.Ho@mgh.harvard.edu.
  • Cheng SH; Department of Radiation Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan. Electronic address: Skye@kfsyscc.org.
  • Sancho G; Department of Radiation Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Electronic address: gsancho@santpau.cat.
  • Offersen BV; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark. Electronic address: birgoffe@rm.dk.
  • Poortmans P; Department of Radiation Oncology, Iridium Kankernetwerk, Wilrijk-Antwerp, Belgium; University of Antwerp, Faculty of Medicine and Health Sciences, Wilrijk-Antwerp, Belgium. Electronic address: philip.poortmans@telenet.be.
Crit Rev Oncol Hematol ; 156: 103090, 2020 Dec.
Article en En | MEDLINE | ID: mdl-33091800
ABSTRACT
Post-operative radiation therapy (RT) reduces loco-regional recurrence rates and mortality in most patients with non-metastatic breast cancer. The aim of this critical review is to provide an overview of the applicability of moderately hypofractionated RT for breast cancer patients, focusing on factors influencing clinical decision-making. An international group of radiation oncologists agreed to assess, integrate, and interpret the existing evidence into a practical report to guide clinicians in their daily management of breast cancer patients. We conclude that moderately hypofractionated RT to the breast, chest wall (with/without breast reconstruction), and regional lymph nodes is at least as safe and effective as conventionally fractionated regimens and could be considered as the treatment option for the vast majority of the patients.For those who are still concerned about its generalised application, we recommend participating in ongoing trials comparing moderately hypofractionated RT to conventionally fractionated RT for breast cancer patients in some clinical circumstances.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Crit Rev Oncol Hematol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Crit Rev Oncol Hematol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article